Control of MAPK signalling: from complexity to what really matters

Jorrit J Hornberg1, Bernd Binder, Frank J Bruggeman

  • 1Department of Molecular Cell Physiology, Institute of Molecular Cell Biology, Faculty of Earth and Life Sciences, Vrije Universiteit, Amsterdam, The Netherlands.

Oncogene
|July 12, 2005
PubMed

Insights

This study reveals that specific reactions, particularly Raf activity, significantly control the epidermal growth factor signaling pathway

Area of Science:

  • Systems Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Oncogenesis arises from altered protein kinetics or abundance in cell signaling networks.
  • Signaling control is often distributed across multiple components, not confined to a single gene.
  • Identifying key reactions is crucial for understanding oncogene function.

Purpose of the Study:

  • To develop and apply a novel method for analyzing control in complex signaling networks.
  • To identify critical reactions governing the epidermal growth factor (EGF)-induced mitogen-activated protein kinase (MAPK) pathway.
  • To understand why certain genes, like Raf, function as oncogenes.

Main Methods:

  • Implementation of control analysis on a detailed kinetic model of the EGF-induced MAPK network.
  • Quantification of reaction control over ERK phosphorylation amplitude, duration, and integrated output.
  • Assessment of distributed control within the signaling network.

Main Results:

  • Control is distributed but non-random, with a few reactions dominating signaling.
  • Raf activity critically controls all characteristics of extracellular signal-regulated kinase (ERK) phosphorylation.
  • Reactions important for one signaling output characteristic are often important for others.

Conclusions:

  • The distributed control of signaling networks can be quantitatively assessed.
  • Raf's central role in controlling ERK phosphorylation dynamics explains its oncogenic potential.
  • The method predicts the impact of mutations and gene expression changes on signaling pathways.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...